Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMPAGLIFLOZIN\METFORMIN for Type 2 diabetes mellitus: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 986 adverse event reports in the FDA FAERS database where EMPAGLIFLOZIN\METFORMIN was used for Type 2 diabetes mellitus.

Most Reported Side Effects for EMPAGLIFLOZIN\METFORMIN

Side Effect Reports % Deaths Hosp.
Diabetic ketoacidosis 312 12.6% 12 251
Blood glucose increased 157 6.3% 3 22
Euglycaemic diabetic ketoacidosis 156 6.3% 4 131
Vomiting 149 6.0% 6 91
Weight decreased 143 5.8% 1 40
Ketoacidosis 139 5.6% 2 105
Nausea 128 5.2% 3 60
Diarrhoea 101 4.1% 2 36
Dizziness 84 3.4% 1 20
Fournier's gangrene 71 2.9% 4 53
Urinary tract infection 66 2.7% 1 38
Fungal infection 64 2.6% 0 4
Acute kidney injury 59 2.4% 3 50
Drug ineffective 52 2.1% 1 4
Abdominal pain 51 2.1% 3 32

Other Indications for EMPAGLIFLOZIN\METFORMIN

Product used for unknown indication (1,032) Diabetes mellitus (353) Type 1 diabetes mellitus (14) Cardiac failure (6) Diabetes mellitus inadequate control (6) Latent autoimmune diabetes in adults (6) Blood glucose increased (5)

Other Drugs Used for Type 2 diabetes mellitus

INSULIN GLARGINE (41,731) METFORMIN (25,080) DULAGLUTIDE (24,742) SEMAGLUTIDE (17,910) INSULIN LISPRO (16,871) EXENATIDE (16,403) TIRZEPATIDE (14,571) EMPAGLIFLOZIN (12,176) CANAGLIFLOZIN (10,795) PIOGLITAZONE (8,418)

Related Pages

EMPAGLIFLOZIN\METFORMIN Full Profile All Type 2 diabetes mellitus Drugs EMPAGLIFLOZIN\METFORMIN Demographics EMPAGLIFLOZIN\METFORMIN Timeline